-Wei Tao Researcher Activity Profile

Research Author Detailed Information 

Wei Tao Publication Rate By Year

Wei Tao has published 1 paper(s) in 2003, 1 paper(s) in 2004, 29 paper(s) in 2007, 7 paper(s) in 2008, for a total of 38 research publications in total.

Wei W Tao Author Information

LAST NAME: tao

FIRST NAME: Wei

INITIALS: w

AFFILIATION:

Papers

Wei Tao's Publication Record

1. [Ultrastructural localization of transcription sites of rRNA genes in the nucleolus of wheat] Year Published: 2004
Department of Biotechnology, Harbin Institute of Technology, Harbin 150001.
2. The application of imaginary method in EEG forward question of eccentric spheres models. Year Published: 2007
Inst. of Electr. Eng., Chinese Acad. of Sci., Beijing.
3. Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Year Published: 2007
Microbiology and Immunology, Walther Oncology Center, Indiana University School of Medicine, 950 West Walnut Street, Room 302, Indianapolis, IN 46202, USA. wetao@iupui.edu
4. [Extended transsphenoidal operation for giant and invasive pituitary adenomas] Year Published: 2007
Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing 100730, China. wangrz@126.com
5. Regulation of myeloid progenitor cell proliferation/survival by IL-31 receptor and IL-31. Year Published: 2007
Department of Microbiology and Immunology, and the Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202-5181, USA. hbroxmey@iupui.edu
6. [The epidemiological investigation of dental caries among 5-year old children in Liaoning province] Year Published: 2007
Department of Preventive Dentistry, School of Stomatology, China Medical University, Shenyang 110002, Liaoning Province, China.
7. [The prevalence and trends of caries in Liaoning province] Year Published: 2007
Department of Preventive Dentistry, School of Stomatology, China Medical University, Shenyang 110002, Liaoning Province, China.
8. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Year Published: 2007
Department of Anesthesiology and Pain Management, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines, Dallas, TX 75390-9068, USA.
9. [An epidemiological investigation of deciduous dental caries among 5375 preschool children aged between 3 to 6 years in Shenyang City] Year Published: 2007
Department of Preventive Dentistry, China Medical University, Shenyang China. chengruibo@sohu.com
10. Predictors of basic and instrumental activities of daily living performance in persons receiving rehabilitation services. Year Published: 2007
Department of Occupational Therapy and Rehabilitation Counseling, Sargent College of Health and Rehabilitation Sciences, Boston University, Boston, MA 02215, USA. wjcoster@bu.edu
11. Hepatocellular glycogen in alleviation of liver ischemia-reperfusion injury during partial hepatectomy. Year Published: 2007
The Center of General Surgery, Chengdu General Hospital of PLA Chengdu Command, Chengdu, China. whjtlj@yahoo.com.cn
12. Kinesin spindle protein (KSP) inhibitors. Part 6: Design and synthesis of 3,5-diaryl-4,5-dihydropyrazole amides as potent inhibitors of the mitotic kinesin KSP. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA. paul_coleman@merck.com
13. Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA. anthony_roecker@merck.com
14. Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. robert_garbaccio@merck.com
15. Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. edward_brnardic@merck.com
16. [The epidemiological investigation of dental caries among 5-year old children in Liaoning province] Year Published: 2007
Department of Preventive Dentistry, School of Stomatology, China Medical University, Shenyang 110002, Liaoning Province, China.
17. [The prevalence and trends of caries in Liaoning province] Year Published: 2007
Department of Preventive Dentistry, School of Stomatology, China Medical University, Shenyang 110002, Liaoning Province, China.
18. Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. robert_garbaccio@merck.com
19. Effects of influent strength on microorganisms in surface flow mesocosm wetlands. Year Published: 2007
Environmental Engineering Program, University of Northern British Columbia, 3333 University Way, Prince George, BC, Canada V2N 4Z9. wdtao@yahoo.com
20. Differentially expressed genes associated with Staphylococcus aureus mastitis of Canadian Holstein cows. Year Published: 2007
Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1.
21. Evolution of genes and genomes on the Drosophila phylogeny. Year Published: 2007
Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York 14853, USA. ac347@cornell.edu
22. Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA. anthony_roecker@merck.com
23. Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. robert_garbaccio@merck.com
24. Improved determination of 5-fluorouracil and its prodrug tegafur in pharmaceuticals by large-volume sample stacking in CE. Year Published: 2007
College of Chemistry & Chemical Engineering, Hunan University, Changsha, China. Fax: +86-731-8821848.
25. Hepatocellular glycogen in alleviation of liver ischemia-reperfusion injury during partial hepatectomy. Year Published: 2007
The Center of General Surgery, Chengdu General Hospital of PLA Chengdu Command, Chengdu, China. whjtlj@yahoo.com.cn
26. Differentially expressed genes associated with Staphylococcus aureus mastitis of Canadian Holstein cows. Year Published: 2007
Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada N1G 2W1.
27. Evolution of genes and genomes on the Drosophila phylogeny. Year Published: 2007
Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York 14853, USA. ac347@cornell.edu
28. Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathway. Year Published: 2008
Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, P.R. China.
29. Blending activity and participation sub-domains of the ICF. Year Published: 2008
Health & Disability Research Institute, Boston University School of Public Health, 580 Harrison Avenue, 4th floor, Boston, MA 02118, USA. ajette@bu.edu
30. Effects of influent strength on microorganisms in surface flow mesocosm wetlands. Year Published: 2007
Environmental Engineering Program, University of Northern British Columbia, 3333 University Way, Prince George, BC, Canada V2N 4Z9. wdtao@yahoo.com
31. Computerized adaptive testing for follow-up after discharge from inpatient rehabilitation: II. Participation outcomes. Year Published: 2008
Health and Disability Research Institute, School of Public Health, Boston University Medical Center, Boston, MA 02118-2639, USA. smhaley@bu.edu
32. [Localization of nucleolar DNA and transcription sites of rRNA genes in situ in wheat cells.] Year Published: 2008
Department of Life Science and Engineering, Harbin Institute of Technology, Harbin 150001, China E-mail: hejie@hit.edu.cn.
33. Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors. Year Published: 2007
Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. edward_brnardic@merck.com
34. Analysis on sensitivity and landscape ecological spatial structure of site resources. Year Published: 2003
School of Geography and Planning, Sun Yat-sen University, Guangzhou 510275, China. zdlizhen@163.net
35. Improved determination of 5-fluorouracil and its prodrug tegafur in pharmaceuticals by large-volume sample stacking in CE. Year Published: 2007
College of Chemistry & Chemical Engineering, Hunan University, Changsha, China.
36. Blending activity and participation sub-domains of the ICF. Year Published: 2008
Health & Disability Research Institute, Boston University School of Public Health, 580 Harrison Avenue, 4th floor, Boston, MA 02118, USA. ajette@bu.edu
37. [Analysis of the first permanent molar caries epidemiological investigation in area of northeast China] Year Published: 2008
Department of Preventive Dentistry, School of Stomatology, China Medical University, Shenyang 110002, China.
38. Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells. Year Published: 2008
Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.